K Aoki1, C Barker, X Danthinne, M J Imperiale, G J Nabel. 1. Howard Hughes Medical Institute, University of Michigan Medical Center, Department of Internal Medicine and Biological Chemistry, Ann Arbor 48109-0650, USA.
Abstract
BACKGROUND: Although recombinant adenovirus vectors are attractive for use in gene expression studies and therapeutic applications, the construction of these vectors remains relatively time-consuming. We report here a strategy that simplifies the production of adenoviruses using the Cre-loxP system. MATERIALS AND METHODS: Full-length recombinant adenovirus DNA was generated in vitro by Cre-mediated recombination between loxP sites in a linearized shuttle plasmid containing a transgene and adenovirus genomic DNA. RESULTS: After transfection of Cre-treated DNA into 293 cells, replication-defective viral vectors were rapidly obtained without detectable wild-type virus. CONCLUSION: This system facilitates the development of recombinant adenoviral vectors for basic and clinical research.
BACKGROUND: Although recombinant adenovirus vectors are attractive for use in gene expression studies and therapeutic applications, the construction of these vectors remains relatively time-consuming. We report here a strategy that simplifies the production of adenoviruses using the Cre-loxP system. MATERIALS AND METHODS: Full-length recombinant adenovirus DNA was generated in vitro by Cre-mediated recombination between loxP sites in a linearized shuttle plasmid containing a transgene and adenovirus genomic DNA. RESULTS: After transfection of Cre-treated DNA into 293 cells, replication-defective viral vectors were rapidly obtained without detectable wild-type virus. CONCLUSION: This system facilitates the development of recombinant adenoviral vectors for basic and clinical research.
Authors: Dan H Barouch; Paul F McKay; Shawn M Sumida; Sampa Santra; Shawn S Jackson; Darci A Gorgone; Michelle A Lifton; Bimal K Chakrabarti; Ling Xu; Gary J Nabel; Norman L Letvin Journal: J Virol Date: 2003-08 Impact factor: 5.103
Authors: Andrea M Vincent; Eva L Feldman; Debbie K Song; Verena Jung; Andreas Schild; Wei Zhang; Michael J Imperiale; Nicholas M Boulis Journal: Neuromolecular Med Date: 2004 Impact factor: 3.843
Authors: Jeffrey A Spencer; Shelby L Hacker; Elaine C Davis; Robert P Mecham; Russ H Knutsen; Dean Y Li; Robert D Gerard; James A Richardson; Eric N Olson; Hiromi Yanagisawa Journal: Proc Natl Acad Sci U S A Date: 2005-02-14 Impact factor: 11.205
Authors: Andrei B Borisov; Sarah B Sutter; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch; Margaret V Westfall; Mark W Russell Journal: Histochem Cell Biol Date: 2005-10-05 Impact factor: 4.304
Authors: Gregory A Graf; Wei-Ping Li; Robert D Gerard; Ingrid Gelissen; Ann White; Jonathan C Cohen; Helen H Hobbs Journal: J Clin Invest Date: 2002-09 Impact factor: 14.808
Authors: Lisa E Hensley; Sabue Mulangu; Clement Asiedu; Joshua Johnson; Anna N Honko; Daphne Stanley; Giulia Fabozzi; Stuart T Nichol; Thomas G Ksiazek; Pierre E Rollin; Victoria Wahl-Jensen; Michael Bailey; Peter B Jahrling; Mario Roederer; Richard A Koup; Nancy J Sullivan Journal: PLoS Pathog Date: 2010-05-20 Impact factor: 6.823